Worldwide distributor of NSN parts and consumables located in the USA.
Send us a request for quote using the form below. Our team will contact you with an up to date pricing and availability quote ASAP.
Medicaments primarily affecting the digestive system put up in measured doses or in forms/pk for retail sale, not elsewhere specified or included
Medicaments, n.E.S., in dosage form or retail packings
Pharmaceutical preparations
Y - Indicates information is in the hazardous materials information resource system (hmirs).
PMICA - Item does not contain precious metal.
CRITL- The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
058770 - Drugs/medicines/vitamins noi
532 - Drugs and medicines excluding pencillin, sulfa, serums, vaccines, and vitamins (not requiring temperature control)
9 - Other or no special handling required (sh)
A - Shipment is not a consolidation and does not exceed 84 inches in any dimension.
M - Medical supplies, equipment, samples, records, etc.
W - Rating variable
Z - No special type of cargo code applicable
Questions & Answers: |
|
What are the historical prices recorded for this stock number? | |
Historical data shows pricing from $22.48 to $37.46.. | |
Does NSN 6505-01-394-5963 have a shelf life? | |
No. There is no shelf life applicable for this NSN. | |
What NATO entities are users of this NSN? | |
Department Of The Army, Department Of The Air Force, U.s. Marine Corps, Department Of The Navy, and New Zealand | |
What is the NIIN of NSN 6505-01-394-5963? | |
013945963 or 01-394-5963 | |
Does NSN 6505-01-394-5963 require demilitarization? | |
Yes - ITAR Controlled | |
What is the most recent solicitation for NSN 6505-01-394-5963? | |
No solicitations for this NSN. | |
When was this national stock number assigned to the federal catalog? | |
Aug 11, 1994 |
Routes of entry: inhalation: no skin: no ingestion: no
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: ondansetron hydrochloride-inhalation:
may cause allergic sensitization. Eyes: severe irritation.
ingestion: may result in a variety of adverse effects.
explanation of carcinogenicity: none
effects of overexposure: nausea, vomiting, irritation.
medical cond aggravated by exposure: persons w/liver disease.
First aid: eyes: flush w/large amounts of cool water for 15 mins. Skin:
wash w/soap & water. Inhalation: give cpr/oxygen if needed.
ingestion: if awake & able to ingest, rinse mouth w/water. Never
give anything by mouth if unconscious/having convulsions. Obtain
medical attention in all cases.
Solubility in water: (see supp)
appearance and odor: clear colorless liquid; odorless
Stability indicator/materials to avoid: yes
stability condition to avoid: light
hazardous decomposition products: ondansetron hydrochloride-thermal:
oxides of nitrogen & hydrochloric acid.
Waste disposal methods: dispose of at an approved facility iaw/federal,
state & local regulations.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: ondansetron hydrochloride *97-4*
cas: 103639-04-9
fraction by wt: 0.2%